Litcius/Paper detail

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

Ilaria Vicenti, Maurizio Zazzi, Francesco Saladini

2021Expert Opinion on Therapeutic Patents126 citationsDOIOpen Access PDF

Abstract

can provide useful information for drug development or drug repurposing to combat SARS-CoV-2 as well as future pandemics.

Topics & Concepts

RNA-dependent RNA polymeraseCoronavirus disease 2019 (COVID-19)VirologyRNARNA polymeraseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RepurposingDrug repositioningDrug developmentPolymeraseDrugPharmacologyBiologyMedicineEnzymeGeneInternal medicineGeneticsInfectious disease (medical specialty)BiochemistryEcologyDiseaseSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyViral Infections and Immunology Research